D. E. Shaw & Co., Inc. - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,767,610
+14.1%
907,413
+235.9%
0.00%
+50.0%
Q1 2024$2,425,866
+657.0%
270,141
+1476.5%
0.00%
Q2 2023$320,443
-81.8%
17,136
-82.2%
0.00%
-100.0%
Q1 2023$1,762,738
-29.7%
96,062
-24.2%
0.00%
-33.3%
Q4 2022$2,508,759
+4.8%
126,705
+27.4%
0.00%0.0%
Q3 2022$2,393,000
-5.1%
99,480
+44.9%
0.00%
+50.0%
Q4 2021$2,521,000
-36.5%
68,648
-46.3%
0.00%
-50.0%
Q3 2021$3,967,000
+160.6%
127,768
+166.8%
0.00%
+300.0%
Q2 2021$1,522,00047,8830.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$53,076,29617.67%
Euclidean Capital LLC 432,900$8,571,4208.02%
GREAT POINT PARTNERS LLC 1,436,569$28,444,0665.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 880,000$17,424,0003.47%
Trustees of Columbia University in the City of New York 73,383$1,4533.00%
Cheyne Capital Management (UK) LLP 71,828$1,422,1942.48%
Deep Track Capital, LP 1,304,940$25,837,8121.08%
Ghost Tree Capital, LLC 125,000$2,475,0001.06%
Perceptive Advisors 1,798,955$35,619,3091.00%
BRAIDWELL LP 1,000,000$19,800,0000.66%
View complete list of RAPT THERAPEUTICS INC shareholders